Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High expression of ID family and IGJ genes signature as predictor of low induction treatment response and worst survival in adult Hispanic patients with B-acute lymphoblastic leukemia.
Cruz-Rodriguez N, Combita AL, Enciso LJ, Quijano SM, Pinzon PL, Lozano OC, Castillo JS, Li L, Bareño J, Cardozo C, Solano J, Herrera MV, Cudris J, Zabaleta J. Cruz-Rodriguez N, et al. Among authors: zabaleta j. J Exp Clin Cancer Res. 2016 Apr 5;35:64. doi: 10.1186/s13046-016-0333-z. J Exp Clin Cancer Res. 2016. PMID: 27044543 Free PMC article.
The homing receptor CD44 is involved in the progression of precancerous gastric lesions in patients infected with Helicobacter pylori and in development of mucous metaplasia in mice.
Garay J, Piazuelo MB, Majumdar S, Li L, Trillo-Tinoco J, Del Valle L, Schneider BG, Delgado AG, Wilson KT, Correa P, Zabaleta J. Garay J, et al. Among authors: zabaleta j. Cancer Lett. 2016 Feb 1;371(1):90-8. doi: 10.1016/j.canlet.2015.10.037. Epub 2015 Nov 27. Cancer Lett. 2016. PMID: 26639196 Free PMC article.
Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL.
Cruz-Rodriguez N, Combita AL, Enciso LJ, Raney LF, Pinzon PL, Lozano OC, Campos AM, Peñaloza N, Solano J, Herrera MV, Zabaleta J, Quijano S. Cruz-Rodriguez N, et al. Among authors: zabaleta j. J Exp Clin Cancer Res. 2017 Feb 28;36(1):37. doi: 10.1186/s13046-017-0506-4. J Exp Clin Cancer Res. 2017. PMID: 28245840 Free PMC article.
Increased expression of deleted in malignant brain tumors (DMBT1) gene in precancerous gastric lesions: Findings from human and animal studies.
Garay J, Piazuelo MB, Lopez-Carrillo L, Leal YA, Majumdar S, Li L, Cruz-Rodriguez N, Serrano-Gomez SJ, Busso CS, Schneider BG, Delgado AG, Bravo LE, Crist AM, Meadows SM, Camargo MC, Wilson KT, Correa P, Zabaleta J. Garay J, et al. Among authors: zabaleta j. Oncotarget. 2017 Jul 18;8(29):47076-47089. doi: 10.18632/oncotarget.16792. Oncotarget. 2017. PMID: 28423364 Free PMC article.
Epigenetics in Hematological Malignancies.
Cruz-Rodriguez N, Combita AL, Zabaleta J. Cruz-Rodriguez N, et al. Among authors: zabaleta j. Methods Mol Biol. 2018;1856:87-101. doi: 10.1007/978-1-4939-8751-1_5. Methods Mol Biol. 2018. PMID: 30178247 Review.
Metabolic pathways enriched according to ERG status are associated with biochemical recurrence in Hispanic/Latino patients with prostate cancer.
Acosta-Vega NL, Varela R, Mesa JA, Garai J, Baddoo MC, Gómez-Gutiérrez A, Serrano-Gómez SJ, Lemus MN, Serrano ML, Zabaleta J, Combita AL, Sanabria-Salas MC. Acosta-Vega NL, et al. Among authors: zabaleta j. Cancer Med. 2023 Feb;12(4):4306-4320. doi: 10.1002/cam4.5301. Epub 2022 Nov 3. Cancer Med. 2023. PMID: 36329628 Free PMC article.
Pegylated arginase I: a potential therapeutic approach in T-ALL.
Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C, Cole J, Rodriguez PC. Hernandez CP, et al. Among authors: zabaleta j. Blood. 2010 Jun 24;115(25):5214-21. doi: 10.1182/blood-2009-12-258822. Epub 2010 Apr 20. Blood. 2010. PMID: 20407034 Free PMC article.
172 results